The historical commentary speaks for itself. The product is fine. What we have never had is formal promotion of the science to the scientific and business community: neither awareness nor marketing programs exist, and the world is still unfamiliar with AS. Here's my bottom line: We were promised a hospital test in California this winter. Let's give it till mid-late March to materialize. Should nothing develop, we already have a shareholder network in place, in order to mobilize, from last year's conference calls. We will pledge enough shares to demand another shareholder meeting, and, this time, since the almighty EPA approval has been given, previously reluctant shareholders who wanted to "wait it out" last year now will have nothing left on which to hang their hats. It will be time to ask all shareholders to do the right thing for the company, its shareholders, and the healthcare community.